Remove Competition Remove Pharma Remove Pharmaceutical manufacturing
article thumbnail

Should we be worried about pharma’s supply chain?

World of DTC Marketing

QUICK READ: Pharma supply chain issues are a concern for us all but especially patients. Hedley Rees has written a book on pharma supply chains that is eye-opening and downright scary. Can patients really be confident in pharma supply chains? Why would a pharma company take risks like these? Patients should be scared.

article thumbnail

Strategic Trends in Pharmaceutical Manufacturing for Industry Leaders

Pharmaceutical Commerce

This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory changes, and evolving market dynamics, requiring industry leaders to adopt innovative strategies in order to remain competitive.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How to get acquisition ready – a seller’s guide to merger and acquisition in pharma

pharmaphorum

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. Since the first wave of consolidation started in 1988, there has been a significant concentration of the pharma industry.

Pharma 119
article thumbnail

Top-10 ways for Pharma to leverage AI according to…AI

Impetus Digital

Manufacturing Optimization While the manufacturing industry lags behind others in terms of AI uptake, there is no shortage of potential ways to leverage this technology. Supply Chain Management Due to geopolitical and climate-related challenges , Pharma supply chain disruptions are becoming increasingly common and complex.

Pharma 92
article thumbnail

AI IN PHARMACEUTICAL MARKETING: Optimizing Automation and Expertise

PM360

Challenges in Implementing AI So, does AI mark the end of laborious processes in pharma marketing? Pharma marketers rely on information technology (IT) expertiseeither internal or outsourcedto evolve back-end technology in lockstep with industry trends. The answer is yes and no.

article thumbnail

Innovative pharma-government partnership to enhance UK clinical trials

European Pharmaceutical Review

A major new £400 million public-private collaboration has launched in the UK, aimed at enhancing the life sciences sector’s economic growth and the competitiveness over the next five years. The post Innovative pharma-government partnership to enhance UK clinical trials appeared first on European Pharmaceutical Review.

article thumbnail

Joint investment to accelerate UK sustainable biomanufacturing

European Pharmaceutical Review

UKRI highlighted that overall, these investments will “enhance the UK’s global competitiveness by supporting research and innovation that leads to new and disruptive biomanufacturing processes across the UK.” Curious about sustainability in pharmaceutical manufacturing and the supply chain?